Hiroko Hitotsumachi

Hiroko Hitotsumachi

Auto-generated profile, based on publicly available information

Hiroko Hitotsumachi

Consortium for Safety Assessment using Human iPS Cells (CSAHi). Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2020 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
TITomoaki Inoue
Tomoaki Inoue
NINorihiko Iwazaki
Norihiko Iwazaki
TATetsuro Araki
Tetsuro Araki
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
Human hepatocytes are essential cell types for pharmacokinetics and the safety evaluation of pharmaceuticals. However, widely used primary hepatocytes with individual variations in liver function lose those functions rapidly in culture. Hepatic cell lines are convenient to use but have low liver functions. Human-Induced Pluripotent Stem (hiPS) cells can be expanded and potentially differentiated into any cell or tissue, including the liver. HiPS cell-derived Hepatocyte-Like Cells (hiPSHeps) are expected to be extensively used as consistent functional human hepatocytes. Many laboratories are investigating methods of using hiPS cells to differentiate hepatocytes, but the derived cells still have immature liver functions. In this paper, we describe the current uses and limitations of conventional hepatic cells, evaluating the suitability of hiPS-Heps to pharmacokinetics and the safety evaluation of pharmaceuticals, and discuss the potential future use of non-conventional non-monolayer culture methods to derive fully functional hiPS-Heps.

3 April 2023
Verified
Other
Open access
SOShuichi Ohkubo
Shuichi Ohkubo
YKYasuo Kodama
Yasuo Kodama
HMHiromi Muraoka
Hiromi Muraoka
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
CYChihoko Yoshimura
Chihoko Yoshimura
KYKazuhiko Yonekura
Kazuhiko Yonekura

3 April 2023
Verified
Other
Open access
SOShuichi Ohkubo
Shuichi Ohkubo
YKYasuo Kodama
Yasuo Kodama
HMHiromi Muraoka
Hiromi Muraoka
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
CYChihoko Yoshimura
Chihoko Yoshimura
KYKazuhiko Yonekura
Kazuhiko Yonekura

3 April 2023
Verified
Other
Open access
SOShuichi Ohkubo
Shuichi Ohkubo
YKYasuo Kodama
Yasuo Kodama
HMHiromi Muraoka
Hiromi Muraoka
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
CYChihoko Yoshimura
Chihoko Yoshimura
KYKazuhiko Yonekura
Kazuhiko Yonekura

3 April 2023
Verified
Other
Open access
SOShuichi Ohkubo
Shuichi Ohkubo
YKYasuo Kodama
Yasuo Kodama
HMHiromi Muraoka
Hiromi Muraoka
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
CYChihoko Yoshimura
Chihoko Yoshimura
KYKazuhiko Yonekura
Kazuhiko Yonekura

3 April 2023
Verified
Other
Open access
SOShuichi Ohkubo
Shuichi Ohkubo
YKYasuo Kodama
Yasuo Kodama
HMHiromi Muraoka
Hiromi Muraoka
HHHiroko Hitotsumachi
Hiroko Hitotsumachi
CYChihoko Yoshimura
Chihoko Yoshimura
KYKazuhiko Yonekura
Kazuhiko Yonekura